Skip to main content

Concierge male endocrinology · London

Male hormone testing, testosterone, LH, FSH, SHBG, prolactin and PSA — the modern male endocrine workup.

A comprehensive male endocrine panel: morning total testosterone (with free / bioavailable), LH, FSH, SHBG, prolactin, oestradiol and PSA — interpreted by a consultant endocrinologist or urologist for hypogonadism, subfertility, prostate health and TRT monitoring.

See the key facts
A consultant endocrinologist reviewing a male hormone panel in a private London clinic

Why patients choose us

  • 01

    The right hands

    We route you to a consultant endocrinologist or urologist — the person interpreting testosterone, LH and FSH decides the answer.

  • 02

    Often answers same-week

    Fasted morning bloods, interpreted within days — with a clear plan for TRT, fertility or pituitary work-up.

  • 03

    Independent, and free

    We are paid by no clinic, so the recommendation is impartial and costs you nothing.

Key facts

Six things to know about the male hormone panel.

Everything a well-informed patient should understand before the blood draw — assay timing, the free-T calculation, and the prostate baseline.

  • Definition

    A male endocrine hormone panel — the core bloods that describe the hypothalamic–pituitary–gonadal axis.

  • Fasted morning testosterone

    Drawn 7–10am when total testosterone peaks diurnally — the only time the number is reliable.

  • Free / bioavailable testosterone

    Calculated from total T, SHBG and albumin — the physiologically active fraction.

  • LH / FSH distinguish 1° vs 2°

    High LH/FSH with low T = primary (testicular). Low or normal LH/FSH with low T = secondary (pituitary).

  • SHBG and albumin needed for free T

    Without SHBG and albumin, free T cannot be calculated — total T alone can mislead.

  • PSA and DRE before TRT

    A prostate baseline (PSA plus digital rectal examination) is standard before testosterone replacement.

The problem

A testosterone result is only as good as who orders and interprets it.

Total testosterone alone is not a diagnosis. SHBG, LH/FSH, prolactin and the time of day decide what the number means — and whether TRT, cabergoline, clomiphene or lifestyle is the right next step.

  • Low energy, low libido, low mood?

    We arrange a properly-timed morning panel and a consultant interpretation — not a self-serve online test.

  • Thinking about TRT?

    Baseline PSA, haematocrit, lipids and a fertility conversation — before the first prescription.

  • Trying to conceive?

    A hormone panel folded into an andrology work-up — clomiphene where TRT would harm fertility.

The diagnostic pathway

From consultation to plan — what happens, in order.

One clinician from first consultation to interpretation — usually within a week.

  1. 01

    Consultation

    Consultation with endocrinologist / urologist

    A focused history: symptoms, libido, mood, energy, fertility plans, prior TRT and pituitary red flags.

  2. 02

    Consultation

    Fasted morning blood test (7–10am)

    A single venous draw at your local phlebotomy or clinic — fasted, at the diurnal peak.

  3. 03

    Investigations

    Confirm low T with a repeat

    Guidelines require two low morning testosterone readings before a diagnosis of hypogonadism is made.

  4. 04

    Investigations

    SHBG + albumin + LH/FSH

    The supporting panel that turns a total T number into a diagnosis — and separates primary from secondary hypogonadism.

  5. 05

    Investigations

    Prolactin and TSH

    Prolactin excludes a prolactinoma; TSH excludes thyroid disease masquerading as low T.

  6. 06

    Onward

    Pituitary MRI if T low + LH low

    Secondary hypogonadism warrants pituitary imaging — a small adenoma is a common, treatable finding.

  7. 07

    Onward

    Personalised plan

    Lifestyle first; TRT, cabergoline or clomiphene where indicated; structured monitoring built in.

Typical end-to-end: 1–2 weeks. Urgent cases (visual field defect, macroadenoma): same week.

What it shows

When a male hormone panel is the right test.

The panel answers specific questions — is testosterone low, why, and what should be done. These are the presentations we see most.

  • Primary hypogonadism

    Low testosterone with high LH/FSH — the testes are failing to respond.

  • Secondary hypogonadism

    Low testosterone with low or inappropriately normal LH/FSH — the pituitary signal is missing.

  • Hyperprolactinaemia (secondary)

    Elevated prolactin suppressing gonadotrophins — usually a pituitary microadenoma.

  • Klinefelter syndrome

    Very low testosterone with markedly raised LH/FSH and azoospermia — karyotype confirms.

  • TRT monitoring

    Serial testosterone, PSA and haematocrit on treatment — safety and efficacy in one panel.

  • Male infertility investigation

    Hormonal component of subfertility work-up — alongside semen analysis and andrology review.

  • Age-related low T

    Symptomatic low testosterone in older men — treated only when symptoms and biochemistry agree.

  • Red flag: markedly elevated prolactin + visual field defect — pituitary MRI urgent

    Suspect a macroprolactinoma. Urgent MRI and endocrinology — not a routine outpatient wait.

Treatment options

Not every low testosterone needs testosterone.

The panel points to a treatment — from lifestyle change to TRT, cabergoline, clomiphene or pituitary surgery.

  • Lifestyle optimisation

    Weight loss, sleep, alcohol reduction — often raises testosterone enough to avoid TRT altogether.

  • Testosterone replacement therapy

    Gel, injection or long-acting depot — chosen with the patient, with baseline PSA, haematocrit and lipids.

  • Cabergoline for prolactinoma

    Dopamine agonist that normalises prolactin, restores testosterone and often shrinks the adenoma.

  • Clomiphene for secondary hypogonadism

    Preserves fertility by driving endogenous LH/FSH — an alternative to TRT when family planning matters.

  • Andrology referral for infertility

    Semen analysis, testicular ultrasound and specialist andrology input alongside the hormone panel.

  • Pituitary surgery (specialist)

    Transsphenoidal resection for macroadenomas, mass effect or dopamine-agonist failure.

  • Structured TRT monitoring

    Testosterone, PSA and haematocrit at 3, 6 and 12 months — then annually — to catch polycythaemia and prostate change early.

  • Multi-disciplinary team review

    Endocrinology, urology and andrology together — for infertility, pituitary disease and complex TRT cases.

Our vetted London network

A small panel of clinicians, we picked them.

Consultant endocrinologists and urologists across central, north, west and south London. Not listed publicly — introductions are made privately, once we understand your case.

Selection criteria

How we choose every clinician in our network.

A modern London endocrinology consulting room
Consultant endocrinologists and urologists
  • Consultant endocrinologists or urologists with a special interest in male hormonal health

  • UKAS-accredited laboratories with validated assays for testosterone, SHBG, LH/FSH and prolactin

  • Same-week interpretation and a written plan, with images available for onward review

  • Onward andrology, fertility or pituitary pathway where the biochemistry demands it

Safety and eligibility

A safe test — when it is done properly.

A hormone panel is a blood test. The safety story is really about who orders it, when it is drawn, and how TRT — if it follows — is monitored.

  • Fasted morning draw

    Blood taken between 7 and 10am, fasted — the only window in which total testosterone is reliably interpretable.

  • Two readings before diagnosis

    Hypogonadism is a diagnosis of two low morning testosterone readings, not one.

  • SHBG and albumin included

    Without them, free testosterone cannot be calculated and a total-T number can mislead in either direction.

  • Prolactin and TSH always

    A prolactinoma or unrecognised thyroid disease will masquerade as simple low T — the panel excludes both.

  • PSA and DRE before TRT

    Baseline prostate assessment is standard before starting testosterone replacement.

  • Haematocrit on TRT

    TRT can drive erythrocytosis — monitored at 3, 6 and 12 months, then annually.

  • Fertility conversation up front

    TRT suppresses spermatogenesis. If fertility matters, clomiphene or gonadotrophin therapy is discussed before the first injection.

  • Not a screening test

    The panel is for men with symptoms or a clinical reason to test — not routine well-man screening.

  • Bring prior bloods and medication list

    Opioids, steroids and some antipsychotics suppress the axis — the medication list changes interpretation.

Red flags we specifically look for

  • Pituitary macroadenoma
  • Prolactinoma with visual field loss
  • Klinefelter syndrome
  • TRT-induced polycythaemia
  • TRT-induced prostate cancer progression
  • TRT-induced sleep apnoea worsening
  • Testosterone abuse (very high T + low LH)
  • Male osteoporosis
  • Male-factor infertility (azoospermia)

Reading your report

A hormone panel report can look intimidating. It isn’t.

Whatever the finding, the report keeps to the same four parts.

A consultant endocrinologist reviewing a male hormone panel on a clinical workstation at a UK private clinic

A quiet reminder

The report is written for your doctor, not for you — and that’s normal.

If you would like us to talk you through it before your follow-up, just ask.

  1. 01 Header

    Indication and symptoms

    Your details, the clinical question, and the symptom pattern that shapes interpretation.

  2. 02 Technique

    Assays and sampling conditions

    Which laboratory, which assay platform, and whether the sample was fasted morning as required.

  3. 03 Findings

    Testosterone, LH, FSH, SHBG, prolactin, PSA

    Value-by-value results with reference ranges, calculated free and bioavailable testosterone, and PSA.

  4. 04 Impression

    The conclusion: read this first

    Normal, primary or secondary hypogonadism, hyperprolactinaemia — and the concrete next step.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover depends on your policy and clinic; we confirm with your insurer before booking.

Frequently asked

Everything we get asked about male hormone testing.

Quick answers on morning timing, primary vs secondary hypogonadism, TRT, prostate safety and fertility.

  • What is included in a male hormone panel?

    The core panel is total testosterone, SHBG, albumin (for calculated free and bioavailable T), LH, FSH, prolactin, oestradiol and PSA — with TSH added to exclude thyroid disease masquerading as low T.

  • Why does the blood test have to be in the morning?

    Total testosterone follows a diurnal rhythm and peaks between 7 and 10am. A number taken in the afternoon can look falsely low and lead to a wrong diagnosis, so the draw must be fasted, morning and — if low — repeated.

  • What is the difference between primary and secondary hypogonadism?

    Primary hypogonadism is testicular failure: testosterone is low and LH/FSH are high because the pituitary is trying to drive the testes harder. Secondary hypogonadism is a pituitary or hypothalamic problem: testosterone is low and LH/FSH are low or inappropriately normal.

  • Do I need testosterone replacement therapy?

    Only if you have symptoms and confirmed low morning testosterone on two occasions, with a reversible cause excluded. Weight loss, sleep and alcohol reduction come first — many men rise back into range without medication.

  • Is TRT safe for the prostate?

    Current evidence does not show that TRT causes prostate cancer, but it can accelerate an existing cancer. A baseline PSA and digital rectal examination are standard before starting, with PSA rechecked at 3, 6 and 12 months.

  • Will TRT affect my fertility?

    Yes — TRT suppresses LH and FSH and therefore spermatogenesis, often severely. If you want children now or in future, clomiphene or gonadotrophin therapy is the right route, not testosterone injections.

WhatsApp Call us

In practice, in London

Booking male hormone testing privately in London — what actually happens

With male hormone testing, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. On the NHS, male hormone testing typically sits behind a triage step and a wait that can stretch from a few weeks into months. In London’s private sector, the same appointment often lands within days. That speed matters when symptoms are disrupting work, sleep, or a plan you’d already committed to — and it’s the single most common reason people call us in the first place.

A private male hormone testing pathway in London usually looks like this: an initial consultation, any diagnostics booked at a nearby facility (most within Zone 1 or 2), and a written report sent to you and your GP within a few days. The consultants we work with hold NHS posts alongside their private lists, which keeps the standards consistent across both settings. For male hormone testing specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

Where a good concierge earns its keep is in the matching. There are dozens of consultants in London who see male hormone testing — but not all of them are the right fit for every case. We narrow it down based on subspecialty, insurer coverage, the specific question being asked, and whether continuity into treatment matters. The right first appointment saves you from repeating yourself later.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

Confidential. We respond within one working day.